Panel discussion

Lonza AG

Date:April 25, 2023
Time:15:30 – 16:15
Room:Marriott Hotel

Panel title

Speed to Clinic

Panel summary

Speed is essential to progress therapeutic candidates from discovery to the clinic. Attaining key milestones as fast as possible is critical for biotech SMEs to make their candidate a success. Lonza and Biotech R&D SMEs will present experiences and discuss solutions aimed at overcoming typical challenges.

Speaker information


Dominik Wegmann, Head of MSAT Ibex Operations at Lonza


Florence Keller, Director, Customer Proposals DPS
Christoph Schäfer, CEO of CIS Pharma AG
Zoë Johnson, Chief Scientific Officer at Affivant Sciences GmbH

Company profile

Lonza is recognized as a CDMO leader for reliable, high-quality services, global capacity, innovative technology platforms and extensive experience. We serve pharmaceutical and biotechnology companies globally striving to help reduce risk and increase chances of success. Our broad capabilities span from pre-clinical to commercialization, for both drug-substance and -product.